Central nervous system disease in hematologic malignancies: historical perspective and practical applications.
about
Response to radiation in renal medullary carcinomaDeveloping interventions for cancer-related cognitive dysfunction in childhood cancer survivorsOutcome of central nervous system relapses in childhood acute lymphoblastic leukaemia--prospective open cohort analyses of the ALLR3 trialMyelotoxicity after high-dose methotrexate in childhood acute leukemia is influenced by 6-mercaptopurine dosing but not by intermediate thiopurine methyltransferase activityClinical characteristics of patients with central nervous system relapse in BCR-ABL1-positive acute lymphoblastic leukemia: the importance of characterizing ABL1 mutations in cerebrospinal fluidAnalysis of the role of intratecal liposomal cytarabine in the prophylaxis and treatment of central nervous system lymphomatosis: The Balearic Lymphoma Group experienceLiposomal cytarabine in the prophylaxis and treatment of CNS lymphoma: toxicity analysis in a retrospective case series study conducted at Polish Lymphoma Research Group CentersIncidence of and risk factors for involvement of the central nervous system in acute myeloid leukemia.Breaking and entering into the CNS: clues from solid tumor and nonmalignant models with relevance to hematopoietic malignancies.A retrospective analysis of treatment-related hospitalization costs of pediatric, adolescent, and young adult acute lymphoblastic leukemiaPrimary diffuse large B-cell lymphoma of the breast: looking at pathogenesis, clinical issues and therapeutic options.Predicting relapse risk in childhood acute lymphoblastic leukaemia.Effectiveness and safety of thiotepa as conditioning treatment prior to stem cell transplant in patients with central nervous system lymphoma.Evaluation and Outcome of Central Nervous System Involvement in Pediatric Acute Lymphoblastic Leukemia in Dar es Salaam, Tanzania.Impact of Initial CSF Findings on Outcome Among Patients With National Cancer Institute Standard- and High-Risk B-Cell Acute Lymphoblastic Leukemia: A Report From the Children's Oncology Group.Oculomotor nerve palsy as a preceding symptom of adult sporadic Burkitt lymphoma: A case report and review of the literatureThe Role of the Central Nervous System Microenvironment in Pediatric Acute Lymphoblastic Leukemia.Role of neuroimaging in children with acute lymphoblastic leukemia and central nervous system involvement at diagnosis.Leukemic blasts are present at low levels in spinal fluid in one-third of childhood acute lymphoblastic leukemia cases.Cellular elements of the subarachnoid space promote ALL survival during chemotherapy.Comparative outcomes of Thai children with acute lymphoblastic leukemia treated with two consecutive protocols: 11-year experience.Craniospinal irradiation prior to stem cell transplant for hematologic malignancies with CNS involvement: Effectiveness and toxicity after photon or proton treatment.Central Nervous System Involvement at the Time of Allogeneic Hematopoietic Stem Cell Transplantation Is Associated with a Poor Outcome in Patients with Acute Myeloid Leukemia.Detection of central nervous system involvement in childhood acute lymphoblastic leukemia by cytomorphology and flow cytometry of the cerebrospinal fluid.Use of a stop-flow programmable shunt valve to maximize CNS chemotherapy delivery in a pediatric patient with acute lymphoblastic leukemia.Involvement of the cerebrospinal fluid cells in children with acute lymphoblastic leukemia: prognostic implications.CARMA1 is a novel regulator of T-ALL disease and leukemic cell migration to the CNS.Neurologic complications of intrathecal liposomal cytarabine administered prophylactically to patients with non-Hodgkin lymphoma.Safety and tolerability of intrathecal liposomal cytarabine as central nervous system prophylaxis in patients with acute lymphoblastic leukemia.[Differential diagnosis of lymphoid infiltrates in the central nervous system: experience of the Network Lymphomas and Lymphomatoid Lesions in the Nervous System].Hypoxic adaptation of leukemic cells infiltrating the CNS affords a therapeutic strategy targeting VEGFA.Efficacy of hematopoietic stem cell transplantation and prophylactic triple intrathecal therapy in a child with multiple CNS relapse of acute lymphoblastic leukemia.Flow cytometric analysis of cerebrospinal fluid in adult patients with acute lymphoblastic leukemia during follow-up.Central nervous system disease in pediatric acute myeloid leukemia.Comparison of conventional cytomorphology, flow cytometry immunophenotyping, and automated cell counting of CSF for detection of CNS involvement in acute lymphoblastic leukemia.Lesions of the central nervous system in leukemia: Pathological and magnetic resonance imaging features at presentation in 14 patients.Toxicity and efficacy of intrathecal liposomal cytarabine in children with leukemia/lymphoma relapsing in the central nervous system: a retrospective multicenter study.Rare case of T-cell lymphoma presenting as acute myelopathy.Chemotactic Cues for NOTCH1-Dependent Leukemia.Detection of Central Nervous System Infiltration by Myeloid and Lymphoid Hematologic Neoplasms Using Flow Cytometry Analysis: Diagnostic Accuracy Study.
P2860
Q24631765-F1B451BA-B408-4CAC-9C81-37BCA466D7E0Q26825655-4F876087-391F-4454-8ABD-8AAC73DC3AA3Q28543517-9C25AE53-B6FD-4B32-B9B9-5A7F86B3EAD7Q33418418-222E37CA-E871-4B86-AC62-95AD68B81DACQ33841347-9C176E13-9BDF-4401-939A-7F2751D8AE9BQ33859877-57756A19-3DDD-47B6-878F-AA4394F7F5A5Q35123219-651B5525-2A75-4FEC-B677-0287DBD00C32Q35563658-D8D63573-3DA9-4BD6-8404-6BEE5241FA1AQ35786301-CCE284D2-1564-4BD5-AB1C-AA4EAC6E9D7CQ36528384-224E0921-6A49-49BA-BDA4-438EAF4118E5Q38109837-C1E164C8-BC79-4729-8362-2040FE2039E8Q38117685-6992B7FE-38FB-4C76-B353-19856AF59A28Q38184642-215E5B00-B597-4BDF-A86E-3731D81AE1EDQ38623368-6D56C283-456C-4BFB-ABB6-6BE380BA48B1Q38769075-D761CBBA-D99D-4235-851B-C87299129A79Q39270336-E8DB984A-93C5-498F-84CF-C90B561FE972Q39297348-3B55A007-D1C1-47F0-B28A-BB1B42AC0CDEQ39459920-29349181-128C-4463-B298-E8CF3C1E684AQ39571116-544819D7-FF84-4E45-9212-135D375487D0Q39602322-EC582584-BF43-4B74-9E2B-84A3F95A4809Q39698824-51C4F21C-F172-4659-B87F-5E432617BCFEQ40151539-B3C9D256-81D3-4DF4-A9BD-400CC43A7D77Q40399440-9375902A-0AB0-476F-A122-23F71C0F4C61Q41643837-2FB11B4B-6FBF-4E72-B7E1-6D10ADC1EF56Q41737657-F1386E83-4B04-4DA4-9DED-980C689FAD31Q42282606-6919BCE5-C08E-44DA-8A0C-1C8A69796346Q42333171-66F26F85-C79D-4525-A94C-27897FDDEC37Q43551846-8616B9CB-44B9-419A-8BDA-D900EBA4BC81Q44313276-1FFD55CC-1903-481E-B722-E6BD4BEC4AF3Q44757897-CC9B4338-CB61-4C4D-BDF3-A1117DB713BBQ45790339-4ED7CCE9-ECF9-4C7F-AB2E-B52D32901A23Q45856706-073B65FD-5174-43DB-9200-731F361D9449Q48118279-FD676C2F-7590-4916-AADA-13EB324A370AQ48156730-A176C9B9-C659-4583-8CC3-11E7EF182929Q48344621-7131FF70-786D-4CD5-AD86-B878856D92C3Q49210894-A7156F0F-BCDB-41FF-BE2F-BD2D19A9ECBAQ51137027-2D654350-63ED-49DE-AF0F-12DBD30868EBQ53724724-A28794CB-603D-4683-A9B2-AE8632D9FBF7Q55235440-418C5739-4575-4458-A7CF-CA67D99FCEA2Q55436913-E36FFA6D-6FCB-402C-AB75-4DECE472143D
P2860
Central nervous system disease in hematologic malignancies: historical perspective and practical applications.
description
2009 nî lūn-bûn
@nan
2009 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Central nervous system disease ...... ve and practical applications.
@ast
Central nervous system disease ...... ve and practical applications.
@en
Central nervous system disease ...... ve and practical applications.
@nl
type
label
Central nervous system disease ...... ve and practical applications.
@ast
Central nervous system disease ...... ve and practical applications.
@en
Central nervous system disease ...... ve and practical applications.
@nl
prefLabel
Central nervous system disease ...... ve and practical applications.
@ast
Central nervous system disease ...... ve and practical applications.
@en
Central nervous system disease ...... ve and practical applications.
@nl
P2860
P1433
P1476
Central nervous system disease ...... ve and practical applications.
@en
P2093
Ching-Hon Pui
Eckhard Thiel
P2860
P304
P356
10.1053/J.SEMINONCOL.2009.05.002
P433
P577
2009-08-01T00:00:00Z